In both analyses, there were no significant differences between any groups of BRCA1 and BRCA2 germline mutation-associated tumors, although nonBRCA ovarian tumors had a significantly higher proportion of BRCA mutational signature than nonBRCA breast tumors (Supplementary Fig. 2a, b). The gene discussed is BRCA1; the disease is breast neoplasm.